In conjunction with our Series E round of funding, Maven appointed three new independent members to our Board of Directors: Yvette Bright, Dr. Jennifer Schneider, and Chris Klomp. We sat down with each of these leaders to learn more about what attracted them to Maven and what they hope to bring to the company in their new positions.
Yvette Bright is the former Executive Vice President and COO of Independence Blue Cross, where she is now a board member. A technologist by training, she spent the first decade of her career at IBM before she joined the Philadelphia-based insurer. Over the course of her 30-year tenure, she rose to become the first woman and person of color to lead their $6 billion Medicare and Commercial books of business.
Yvette also serves on the boards of Cityblock Health, National Life Group, CSAA Insurance Group (AAA affiliate), and Myers Industries.
What about Maven’s mission resonates with you?
Maven’s mission resonates because of the experiences I’ve had over my thirty years in healthcare. As an African American woman, I’m deeply interested in helping to improve the childbirth outcomes for minority women in this country. I have had my own personal challenges with reproductive health, including a premature birth with my first child, emergency c-sections, and a three-week NICU stay for my son. I also have family members who couldn’t not bear children, and didn’t have guidance, resources, or a platform like Maven’s. I understand how difficult it can be, emotionally and physically. It is so exciting to think about Maven putting forth a digital platform where women and families can access quality healthcare, and have round-the-clock support. I didn’t have that. My family members didn’t have that.
What excites you about joining the Maven Board of Directors at this point in the company’s journey?
I feel like I'm joining at a transformative moment. There's a lot of white space to create what the experience should look like for women and families as it relates to their healthcare, particularly their reproductive health. This is a moment where Maven is thinking about its future product offerings, its strategy, and how to deliver end-to-end care, and I look forward to having the opportunity to contribute to and influence our decision-making in these critical areas. Especially in the wake of the Dobbs decision, at a time when women are feeling like the clock has been turned back and they really have nowhere to turn for guidance and support, here’s Maven paving the way with a quality digital health platform that can level the playing field.
.svg)
.png)
%20(1).jpeg)
.jpeg)
.jpeg)
